Affymax/Takeda files new drug application (NDA) for peginesatide to treat anemia. Print
Pharma Business Review: Affymax and Takeda Pharmaceutical have filed a new drug application (NDA) for experimental drug peginesatide (formerly known as Hematide) as the treatment for anemia linked with chronic renal failure (CRF) in adult patients on dialysis, with the US Food and Drug Administration (FDA).

...